 | | Vol. 8.34 – 7 November, 2022 |
| |
|
|
| The authors showed that melanoma cells interacted with nociceptor neurons, leading to increases in their neurite outgrowth, responsiveness to noxious ligands and neuropeptide release.
[Nature] |
|
|
|
 | | PUBLICATIONSRanked by the impact factor of the journal |
| | DERMAL STEM CELLS & TISSUE REGENERATION |
|
|
|
| Scaffolding materials with integrated layer structures and well interconnected and open pore structures were obtained.
[International Journal of Biological Macromolecules] |
|
|
|
| An in vitro wound model was developed by allowing the HaCaT cells to form a confluent monolayer, then scratching the cells with a pipette tip to form a wound.
[Scientific Reports] |
|
|
|
| In vitro, a novel recombinant expression vector, pcDNA3.1(-)-VEGF, was produced and transfected into fibroblast cells. Following selecting fibroblast cells with hygromycin, recombinant cells were investigated in terms of VEGF expression.
[Scientific Reports] |
|
|
|
| Investigators studied the effects of organic UV filters on hyaluronan metabolism and skin hydration in human HaCaT keratinocytes.
[Toxicology in Vitro] |
|
|
|
| | Scientists performed integrative transcriptomic and proteomic analyses on emerging immuno-oncology targets across multiple clinical cohorts of melanoma under anti-PD-1 treatment, on both bulk and single-cell levels.
[Cancer Cell] |
|
|
|
| The effects of YTH N6–methyladenosine RNA binding protein 3 (YTHDF3) and lysyl oxidase–like 3 in melanoma were verified in vitro and in vivo.
[Clinical and Translational Medicine] |
|
|
|
| Researchers aimed to assess the effectiveness of machine-learning algorithms in predicting melanoma recurrence using clinical and histopathologic features from Electronic Health Records.
[npj Precision Oncology] |
|
|
|
| A vemurafenib-resistant BRAFV600E melanoma cell line was established by gradually increasing the drug concentration.
[Endocrine] |
|
|
|
|
| Investigators systematically review and meta-analyze evidence regarding the association of menopausal hormone thereapy with the risk of melanoma and keratinocyte cancer.
[Maturitas] |
|
|
|
| The authors summarize m6A methylation functions in different skin cancers, and discuss how m6A methylation is involved in disease development and progression.
[Experimental Dermatology] |
|
|
|
|
| The FDA commits to exploring alternative methods to replace laboratory animals in developing new drugs and products.
[Nature News] |
|
|
|
|
| February 13 – 16, 2023
Breckenridge, Colorado, United States |
|
|
|
|
|
| | Sanofi – Amsterdam, Netherlands |
|
|
|
| | University of Nebraska Medical Center – Omaha, Nebraska, United States |
|
|
|
| | The University of Texas M. D. Anderson Cancer Center – Houston, Texas, United States |
|
|
|
| | The University of British Columbia – Vancouver, British Columbia, Canada |
|
|
|
| | Wellcome Genome Campus – Saffron Walden, England, United Kingdom |
|
|
|
|
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
